Table: Kaken Pharmaceutical -2016/17 group results

KAKEN PHARMACEUTICAL

10/05/2017 05:30

May 10 (Reuters)-  
          Kaken Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales          101.48          109.73         101.70        51.10     
               (-7.5 pct)      (+16.9 pct)    (+0.2 pct)    (-2.1 pct)  
  Operating       30.71           35.15          26.80        14.70     
               (-12.6 pct)     (+70.4 pct)    (-12.7 pct)   (-8.8 pct)  
  Recurring       30.98           35.37          27.00        14.80     
               (-12.4 pct)     (+73.4 pct)    (-12.9 pct)   (-8.9 pct)  
  Net 
  Net             22.02           21.14          19.10        10.40     
               (+4.1 pct)      (+74.4 pct)    (-13.2 pct)   (-9.1 pct)  
  EPS          536.70 yen      510.54 yen     467.32 yen    254.46 yen  
  Ann Div      150.00 yen                     150.00 yen                
  -Q2 Div       75.00 yen       34.00 yen      75.00 yen                
  -Q4 Div       75.00 yen       78.00 yen      75.00 yen                
   
  NOTE - Kaken Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T 
  ((Tokyo Headline News Desk +813 6441 1812))